← back to search

Xinrong Li

Fudan University · CN
Area of research
Cancer Research · Cognitive Neuroscience
Research interest
Research focused on Moxibustion and microRNA, with related work in Dopaminergic, Immune system, Amisulpride. Notable publications include 'Preliminary comparison of plasma notch-associated microRNA-34b and -34c levels in drug naive, first episode depressed patients and healthy controls', 'Moxibustion Exerts a Neuroprotective Effect through Antiferroptosis in Parkinson’s Disease', and 'Moxibustion Protects Dopaminergic Neurons in Parkinson’s Disease through Antiferroptosis'.
h-index
citations
66
works
5
NIH funding
primary concept
email

Recent publications

The safety and efficacy of gamma frequency auditory and visual stimulation in the treatment of alzheimer’s disease: a systematic review and meta-analysis
Translational Psychiatry 2025cited by 1position: middledoi
[Corrigendum] miR‑335 promotes ferroptosis by targeting ferritin heavy chain 1 in in vivo and in vitro models of Parkinson's disease
International Journal of Molecular Medicine 2025cited by 0position: firstdoi
Elevated choline drives KLF5-dominated transcriptional reprogramming to facilitate liver cancer progression
Oncogene 2024cited by 10position: firstdoi
Refining antipsychotic treatment strategies in schizophrenia: discovery of genetic biomarkers for enhanced drug response prediction
Molecular Psychiatry 2024cited by 7position: middledoi
Exploration of the relationship between hippocampus and immune system in schizophrenia based on immune infiltration analysis
Frontiers in Immunology 2022cited by 14position: middledoi
Moxibustion Protects Dopaminergic Neurons in Parkinson’s Disease through Antiferroptosis
Evidence-based Complementary and Alternative Medicine 2021cited by 18position: middledoi
Moxibustion Exerts a Neuroprotective Effect through Antiferroptosis in Parkinson’s Disease
Evidence-based Complementary and Alternative Medicine 2019cited by 31position: middledoi
Preliminary comparison of plasma notch-associated microRNA-34b and -34c levels in drug naive, first episode depressed patients and healthy controls
Journal of Affective Disorders 2016cited by 74position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Dongfeng Chen · Guangzhou University of Chinese Medicine3 papers (2019–2025)Xuelei Liu · Guangzhou University of Chinese Medicine3 papers (2019–2025)Xiaoqian Hao · Guangzhou University of Chinese Medicine2 papers (2021–2025)Xinzhe Du · Shanxi Medical University2 papers (2022–2025)Caiping Zhao · Guangzhou University of Chinese Medicine2 papers (2019–2025)Zhifen Liu · Guangzhou University of Chinese Medicine2 papers (2016–2022)Shanyu Ye · Guangzhou University of Chinese Medicine2 papers (2021–2025)Wenwen Si · Guangzhou University of Chinese Medicine2 papers (2021–2025)Zifeng Huang · Guangzhou University of Chinese Medicine2 papers (2021–2025)Meiling Zhu · Guangzhou University of Chinese Medicine2 papers (2021–2025)Yichun Ji · Guangzhou University of Chinese Medicine2 papers (2021–2025)Ye Tian · Southern Medical University2 papers (2019–2025)Sha Liu · Shanxi Agricultural University2 papers (2022–2025)Junxia Li · Chinese Academy of Sciences1 papers (2022–2022)Guiyu Zhang · Guangzhou University of Chinese Medicine1 papers (2019–2019)Zhixiang Hu · Fudan University1 papers (2024–2024)Juan Lu · Guangzhou University of Chinese Medicine1 papers (2019–2019)Lei Lei · Zhejiang International Studies University1 papers (2016–2016)Yong Xu · Guangdong University of Technology1 papers (2022–2022)Tingting Wang · Guiyang Medical University1 papers (2019–2019)